ArticleThe American journal of bioethics : AJOB2018
The Ethics of Smart Pills and Self-Acting Devices: Autonomy, Truth-Telling, and Trust at the Dawn of Digital Medicine.
Article in The American journal of bioethics : AJOB, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Digital Phenotyping in Bipolar Disorder: Which Integration with Clinical Endophenotypes and Biomarkers?International journal of molecular sciences · 2020Pooled it
- Adherence to Oral Antipsychotics Measured by Electronic Adherence Monitoring in Schizophrenia: A Systematic Review and Meta-analysis.CNS drugs · 2020Pooled it
- Technological innovation in healthcare: challenges, opportunities and impact on sustainability.Frontiers in digital health · 2026Review
- Ethical, legal, and social issues related to ingestible, implantable electronic devices and mRNA delivery devices.Device · 2025Article
- Trust in Medical AI: The Case of mHealth Diabetes Apps.Journal of evaluation in clinical practice · 2025Article
- Digital interventions in medication adherence: a narrative review of current evidence and challenges.Frontiers in pharmacology · 2025Review
- Ethics of Wearable-Based Out-of-Hospital Cardiac Arrest Detection.Circulation. Arrhythmia and electrophysiology · 2024Review
- Patients' UX Impact on Medication Adherence in Czech Pilot Study for Chronically Ill.Behavioral sciences (Basel, Switzerland) · 2024Article
- Review article: Current status and future directions of ingestible electronic devices in gastroenterology.Alimentary pharmacology & therapeutics · 2024Review
- Healthiness as a Virtue: The Healthism of mHealth and the Challenges to Public Health.Public health ethics · 2023Article
- Artificial Intelligence's Impact on Drug Discovery and Development From Bench to Bedside.Cureus · 2023Review
- Your robot therapist is not your therapist: understanding the role of AI-powered mental health chatbots.Frontiers in digital health · 2023Article
- Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy.Current HIV/AIDS reports · 2022Review
- Data-enriched edible pharmaceuticals (DEEPs): Patients' preferences, perceptions, and acceptability of new dosage forms and their digital aspects - An interview study.Exploratory research in clinical and social pharmacy · 2022Article
- A Value-centered Exploration of Data Privacy and Personalized Privacy Assistants.Digital society : ethics, socio-legal and governance of digital technology · 2022Article
- Scoping Review of the Literature on Smart Healthcare for Older Adults.Yonsei medical journal · 2022Article
- Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective.Pulmonary therapy · 2021Review
- Internet of things issues related to psychiatry.International journal of bipolar disorders · 2021Review
- Family- and Person-Centered Interdisciplinary Telehealth: Policy and Practice Implications Following Onset of the COVID-19 Pandemic.Journal of gerontological nursing · 2020Article
- Involving patients as key stakeholders in the design of cardiovascular implantable electronic device data dashboards: Implications for patient care.Heart rhythm O2 · 2020Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Digital medicine is a medical treatment that combines technology with drug delivery. The promises of this combination are continuous and remote monitoring, better disease management, self-tracking, self-management of diseases, and improved treatment adherence. These devices pose ethical challenges for patients, providers, and the social practice of medicine. For patients, having both informed consent and a user agreement raises questions of understanding for autonomy and informed consent, therapeutic misconception, external influences on decision making, confidentiality and privacy, and device dependability. For providers, digital medicine changes the relationship where trust can be verified, clinicians can be monitored, expectations must be managed, and new liability risks may be assumed. Other ethical questions include direct third-party monitoring of health treatment, affordability, and planning for adverse events in the case of device malfunction. This article seeks to lay out the ethical landscape for the implementation of such devices in patient care.
Indexed as
Identifiers
30235091What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.